Main goal of this study is to detect the possible alterations in microRNA (miRNA) expression and the pathway targeted in plasma at the time of embryo transfer and pregnancy testing dependent on the assisted reproductive treatment (ART) outcome after ovarian hyperstimulation for in vitro fertilization. Changes in miRNA expression in plasma of women, who became pregnant (n = 6) vs women who failed implantation (n = 6) following day 5 embryo transfer (ET), were investigated at the day of ET and pregnancy testing (PT). Protein expression to validate the finding was performed with a sample size of n = 20 (10 per group) using enzyme-linked immunosorbent assay. Enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed using DIANA-miRPath, v3.0 software based on predicted targets by DIANA-microT-CDS. 4 miRNAs could be identified as possible biomarkers for implantation success. The 11 miRNAs showing the highest significant alterations were all associated with the regulation of WNT3 and WNT7a. While WNT7a presented with a significant decrease between ET and PT in case of ongoing pregnancy, women with implantation failure showed unaltered concentrations. WNT3 presented with a significant decrease in both groups. However, the loss of WNT3 between ET and PT was significantly higher in patients who became pregnant. Main limitation of this prospective study is its small sample size, defining it as a pilot analysis. To conclude, we could demonstrate a significant change in miRNA profile dependent on the ART outcome affecting Wnt pathway. Our findings indicate a possible prospective use of miRNA as biomarkers for implantation success.
Introduction
MicroRNAs (miRNAs) are small, non-coding singlestranded RNA of about 18-25 nucleotides (MoralesPrieto & Markert 2011 , Zeng et al. 2012 , Galliano & Pellicer 2014 , Floris et al. 2016 ). They are not translated into proteins, but they interfere with translated RNA and play a major role in many biological processes, including cell proliferation and differentiation, metastasis and apoptosis by post-transcriptional regulation of gene expression (Zeng et al. 2012 , Zhu et al. 2015 . Their regulation impact is either negatively by mRNA cleavage, deadenylation and translational repression or positively by targeting gene promoters (Galliano & Pellicer 2014) . It is estimated that there are about 50,000 miRNAs within introns or other genes (host genes) or as independent transcriptional units in the mammalian cell (Galliano & Pellicer 2014) , influencing about 30-50% of the genome expression (Zeng et al. 2012 , Zhu et al. 2015 . Many miRNAs can bind and regulate more than 200 mRNAs (messenger RNAs) (Galliano & Pellicer 2014) . miRNAs are detectable in different biological fluids, such as human plasma (Morales-Prieto & Markert 2011 , Zeng et al. 2012 . Usually, hybridizationbased microarray platforms and quantitative real-time polymerase chain reaction (qRT-PCR) are used to identify miRNA aberrations. These methods detect only known or relatively abundant miRNA. Progress in detection technique due to next-generation sequencing promises to measure the absolute abundance as well as to detect novel miRNAs (Zhu et al. 2015) .
Different miRNA alterations have been validated in many reproductive and obstetric conditions, e.g. implantation, ectopic pregnancy, miscarriage or obstetric complications such as preeclampsia or gestational diabetes mellitus (GDM) (Cretoiu et al. 2016 , Loux et al. 2017 , Shi et al. 2017 . miRNA also plays a major role during the implantation process. They are secreted during embryogenesis and can be analyzed in spent blastocyst media for human embryo competence assessment (Capalbo et al. 2016) . It applies only for blastocyst stage, not for cleavage and morula stage (Liu et al. 2015 , Capalbo et al. 2016 . Even early steps during embryogenesis lead to an altered miRNA profile, for example, the miR-518d-5p plays an important role in sexual differentiation (Liu et al. 2015) .
Receptive endometrium also shows alterations in the miRNA profile. Levels of the miRNA-30-family or lethal 7 are increased within the window of implantation (Liu et al. 2015) . The let-7-family is one of the most evaluated subgroups during implantation. They consecutively modulate the expression profile of other miRNAs. They also target Muc1, a protein, which plays a crucial role during embryo attachment (Liu et al. 2015) .
One of the most important miRNA groups for implantation is the 17-92-cluster, which targets transforming growth-factor beta (TGFB), SMAD2 or SMAD 4 and Wnt signaling (Landskroner-Eiger et al. 2015 , Liu et al. 2015 . The transcription of this cluster is activated by C-myc, N-myc or E2F2, and many miRNAs of this cluster are altered in pregnancy disorders affected by implantation failure (Fu et al. 2013 , Liu et al. 2015 .
The aim of this study was to detect the possible alterations in miRNA expression and the pathway targeted in plasma of women at the time of embryo transfer and pregnancy testing dependent on the ART outcome after ovarian hyperstimulation for in vitro fertilization. The primary goal is to enhance the knowledge about the miRNA profile during implantation and in early pregnancy to evaluate possibly miRNAs as maternal biomarkers for ART outcome.
Methods
Blood samples were obtained after informed consent from women (n = 20) undergoing ovarian hyperstimulation to perform in vitro fertilization by IVF or ICSI. The study was approved by the Ethical Committee of the Heidelberg University (protocol S572/2014). Embryo transfer was performed on day 5 after oocyte retrieval in all patients. Patients were divided into two groups:
(1) pregnancy test positive and (2) pregnancy test negative. No biochemical pregnancy was observed in both groups.
Molecular profiling of maternal plasma of women, who became pregnant vs. women who failed implantation was done at the day 5 embryo transfer (ET) and pregnancy testing (day 14, PT), allowing for paired analysis and investigating the change of miRNA abundance per individual using the Human miRNA Microarray Kit Release 21.0, which represented 2549 human miRNAs.
Isolation of miRNAs
miRNAs were isolated from plasma as described by the manufacturer: 1 mL QIAzol Lysis Reagent were mixed with 200 µL sample and incubated for 5 min. 3.5 µL miRNeasy plasma Spike-In Control were added before adjoining 200 µL chloroform. After waiting 3 min, samples were centrifuged for 15 min at 12,000 g at 4°C. The upper aqueous phase was transferred to a new tube and mixed with 900 µL 100% ethanol. 700 µL of the sample were pipetted into RNeasy MinEluta spin column, followed by centrifugation at 8000 g for 15 s at room temperature. The remaining sample was processed in the same way. Afterwards, 700 µL Buffer RWT were added, followed by centrifugation at 8000 g for 15 s at room temperature. 500 µL Buffer RPE were added subsequently, followed again by centrifugation at 8000 g for 15 s at room temperature. 500 µL of 80% ethanol were added, followed by centrifugation for 2 min at 10,000 g. RNeasy MinElute was placed with 14 µL RNase-free water, followed by centrifugation at full speed for 1 min.
Microarray hybridizations were done following the manufacturer's recommendations. In brief, a total of 100 ng total RNA from each sample was dephosphorylated by incubation with calf intestinal phosphatase at 37°C for 30 min and denatured with the use of 100% dimethyl sulfoxide at 100°C for 10 min. Samples were labeled with pCp-Cy3 with the use of T4 ligase at 16°C incubation for 2 h. Each labeled RNA sample was hybridized onto an individual sub-array of the 8 × 60 K format Agilent miRNA microarray slide, with each array containing probes for 2549 human miRNAs according to miRBase, v21. Then, the microarrays were loaded and incubated at 55°C for 20 h with 20 rpm rotation. After two washing steps, the arrays were dried and scanned using the Agilent Microarray Scanner at 3 microns resolution in double path mode. Data were acquired using Agilent AGW Feature Extraction software, version 10.10.11 (Agilent Technologies).
Quality control of isolated RNA
Quantity and quality of RNA were first determined by measuring absorbance at 260 and 280 nm with a NanoDrop 1000 spectrophotometer according to the manufacturer's instructions (Thermo Scientific). Samples were further analyzed for their RNA integrity with an Agilent 2100 BioAnalyzer and RNA 6000 Nano Kits (Agilent) according to the manufacturer's protocol.
Pathway analysis
Enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses was performed using DIANA-miRPath, v3.0 software based on predicted targets by DIANA-microT-CDS Targets of miRNAs with a score of more than 0.8 were selected. Only KEGG pathways with a P value <0.05 and a false discovery rate (FDR) <0.05 were retained.
Enzyme-linked immunosorbent assay (ELISA) assays
Plasma samples were obtained and centrifuged for 20 min, 1200 g, 10°C. WNT3 and WNT7a were measured through ELISA (Cusabio, Wuhan, China). Standards, samples and reagents were prepared as described in manufacturer's instruction. 100 µL of standard and sample were added to each well and incubated for 2 h. After removal of the liquid, 100 µL www.reproduction-online.org
Reproduction (2017) 154 799-805 biotin-antibody were added to each well and incubated for 1 h. After aspirating the liquid and washing the wells, 100 µL HRP-avidin were used, followed by incubation (1 h). By the end of incubation, wells were washed again and incubated with 90 µL TMB substrate for 25 min. Reactions were arrested using 50 µL stop solution. Optical density of each well was measured within 5 min, using a microplate reader set to 450 nm with wavelength correction of 570 nm.
Results
No significant differences concerning age, BMI or embryo quality was observed between the two groups. There was no difference in age (34.67 years vs 36.67 years, P = 0.26), blastocyst quality number of oocytes retrieved (9.7 (pregnant) vs 13.7 (non-pregnant) P = 0.13). The body mass index in the groups 1 and 2 were not different (25.04 kg/m 2 (group 1) vs 24.25 kg/m 2 (group 2), P = 0.61) ( Table 1) . We could identify significant altered miRNAs in patients who did not show implantation comparing ET vs PT, in patients who showed implantation comparing ET vs PT and in patients with and without implantation at the timepoint PT. Significant altered miRNA profile is demonstrated in Tables 2, 3 and 4. However, no significant alteration in patients with and without implantation at the timepoint ET could be observed. miRNAs with the most powerful change in AUC were hsa-miR-718 (P = 0.12, AUC = 0.14), hsamiR-4634 (P = 0.07, AUC = 0.17) and hsa-miR-6510-5p (P = 0.35, AUC = 0.22).
By comparing cases with clinical pregnancy after day 5 transfer with patients whose embryos did not implant, we observed 5 miRNAs that presented with two significant alterations (miR-5001, miR-4632, miR-4327, miR-5739 and miR-1249) between the two groups that were analyzed. As an example of such changes in The significant altered miRNAs were all downregulated at the timepoint of PT compared to ET in women without implantation. 2 miRNAs (miR-6800-5p, miR-1249-3p) were downregulated at the timepoint of PT compared to ET, the remaining miRNAs that showed significant alterations were upregulated at the timepoint of PT compared to ET.
normalized expression intensity, a boxplot of miRNA 5739 and miRNA 4327, both of which behave similar to HCG, at the timepoint of PT dependent on ART outcome is shown in Fig. 1 . Systems biology analysis using DIANA-miRPath, v3.0 of miRNA alterations highlighted 331 genes that have been experimentally validated as targets of altered miRNAs (Vlachos et al. 2012) .
Further analysis showed that the 11 miRNAs with the highest amount of significant alterations or the highest effect size were all associated with the regulation of WNT3 and WNT7a. Other proteins that seemed to be associated with these 11 miRNAs were the following: OTX1, WNT4, IGF1R, ACVR2B, PCGF5, R1F1, AXIN2, PIK3R1, FGF2, IGF1, BMPR1A and MAP2K1.
ELISA results
In patients who got pregnant, Wnt7a protein, as determined by ELISA, was significantly different between ET (207.18 ± 6.15 pg/mL) vs PT (178.81 ± 10.21 pg/mL) (P = 0.02) (Fig. 2) . In non-pregnant patients, WNT7a protein was not different between ET (190.37 ± 13.06 pg/ mL) vs PT (192.48 ± 23 .89 pg/mL) (P = 0.90) (Fig. 2) . Similarly, WNT7a protein was not significantly different neither in ET between pregnant vs non-pregnant The altered miRNAs were increased in women with ongoing pregnancy compared to women without implantation at the timepoint of PT. patients (207.18 ± 6.15 vs 190.37 ± 13.06, P = 0.18) nor in PT between pregnant vs non-pregnant patients (178.81 ± 10.21 vs 192.48 ± 23.89, P = 0.54). WNT3 protein, as determined by ELISA, was significantly different between ET (0.417 ± 0.073 ng/ mL) vs PT (0.200 ± 0.034 ng/mL) (P = 0.03) in pregnant patients. In non-pregnant patients, WNT3 protein was different between ET (0.351 ± 0.021 ng/mL) vs PT (0.236 ± 0.021 ng/mL) (P < 0.01). Between pregnant vs non-pregnant patients, WNT3 protein was not different neither in ET (0.417 ± 0.073 vs 0.351 ± 0.021 ng/ mL, P = 0.33) nor in PT between pregnant vs nonpregnant patients (0.200 ± 0.034 vs 0.236 ± 0.021 ng/ mL, P = 0.27). However, the relative loss of ET vs PT was different between pregnant (2.06 ± 0.29) and nonpregnant (1.57 ± 0.16) patients (P = 0.03) (Fig. 3) .
Discussion
This pilot study is, to the best of our knowledge, the first one analyzing the miRNA profile dependent on ART outcome in plasma of women at the time of embryo transfer and pregnancy test. Despite the potential use of miRNAs as biomarker in various medical conditions (Zeng et al. 2012 , Galliano & Pellicer 2014 , MoralesPrieto et al. 2014 , Landskroner-Eiger et al. 2015 , Virant-Klun et al. 2015 , Zhu et al. 2015 , Capalbo et al. 2016 , Floris et al. 2016 , miRNAs play a crucial role in implantation (Galliano & Pellicer 2014 , Liu et al. 2015 , Virant-Klun et al. 2015 , Borges et al. 2016 , Ioannidis & Donadeu 2016 . In our study, we could show that miR-5001, miR-4632, miR-4327, miR-1249-3p and miR-5739 presented with two significant alterations in the four analyses performed. While miR-1249 seems to decrease typically between embryo transfer and pregnancy test irrespective of ART outcome, miR-5739 is changed dependent on the ART outcome. miR-5739 is significantly increased in case of a positive pregnancy test compared to a negative pregnancy test. It also shows significantly higher levels at the timepoint of PT compared to ET in case of an implanted embryo. This observation spotlights miR-5739 as a possible biomarker for IVF success. Among other things, miR-5739 has been shown to modulate the endoglin network in endothelial cells derived from human embryonic stem cells (Yoo et al. 2011) . However, further analysis with a larger study cohort should be performed in order to verify if miR-5739 or another of the altered miRNAs in our study could present a biomarker for IVF success.
Another central role in our interaction network is represented by the modulation of miR-4327 that shows the same kind of regulation as miR-5739 with a slightly smaller effect size and reveals also a possible role as biomarker for IVF success. It targets genes like HOXA3, KLF9 or MAP3K2 that are known to play an important role in embryonic development and implantation (Gao et al. 2010 , Heard et al. 2012 , Kranc et al. 2017 ).
However, miR-5001 and -4632, in contrast to the dynamics of miR-4327 and -5739, decrease significantly at the time of pregnancy testing when no pregnancy was achieved. These two miRNAs also feature as possible biomarker for IVF success. Further analysis will show if one of these four miRNAs alone represents higher diagnostic value than the measurement of human choriogonadotropin (hCG).
Increasing knowledge about miRNA function in different medical constellations emphasizes their important role in posttranscriptional regulation. However, as miRNAs target different mRNAs (Revel et al. 2011) , it is difficult to identify targeted pathways by analyzing only isolated miRNAs. Therefore, we tried to identify the complete miRNA profile that is influenced by the ART outcome in order to correlate this profile with the pathway most likely targeted. By using the 11 miRNAs with the highest significant alterations in our analysis, we discovered that they were all associated with the regulation of WNT 3 and WNT7a, essential proteins of the Wnt pathway, that was recently described as critical for early embryonic development, as well as for the luteal transformation of the endometrium (Chen et al. 2009 , Sonderegger et al. 2010 , Tepekoy et al. 2014 ). This pathway consists of different proteins playing an important role in cell differentiation, apoptosis, proliferation and determination of cell fate (Tepekoy et al. 2014) . In addition, miRNA regulation of this pathway has also been described in oncological conditions (Lu et al. 2016) .
Wnt family members are expressed in the reproductive tract, especially Wnt4, Wnt5a and WNT7a (associated with the altered miRNA in our study) (Hayashi et al. 2011 , Tepekoy et al. 2014 . Furthermore, endometrial receptivity seems to be regulated by the Wnt pathway (Tepekoy et al. 2014) , as Wnt7a, Wnt3, Wnt3a and Wnt1 have been associated with essential peri-implantation endometrial changes in humans and mammals (Chen et al. 2009 , Sonderegger et al. 2010 , Tsang et al. 2012 , Tepekoy et al. 2014 , Goad et al. 2017 .
Wnt pathway does not only play a crucial role in maternal receptivity, but is also involved in early embryo development and organ formation. Last, but not least, the Wnt family plays a role in embryo hatching, adhesion and implantation (Kemp et al. 2007 , Tepekoy et al. 2014 , Virant-Klun et al. 2015 , HosseinNia et al. 2016 . It is thought to be a key factor in the embryo-endometrial crosstalk (Chen et al. 2009 , Sonderegger et al. 2010 . For example, baicalin, a monomer of flavonoids, was shown to promote embryo adhesion via the Wnt pathway (Zhang et al. 2015) . Our findings support these studies and the Wnt pathway may represent a link between ART outcome and miRNA profile established in our analysis (Kemp et al. 2007) .
Main limitation of this prospective study is its small sample size, defining it as a pilot analysis that requires further validation in a prospective clinical trial allowing to define the best biomarker among the altered miRNAs and possibly detecting even more miRNAs and related proteins predicting implantation success. Another limitation is the possible influence of other medical conditions changing the miRNA profile. Even if we could exclude the most important confounders, it has to be admitted that various medical conditions can execute their effect on the same miRNAs.
Conclusions
The presented results from our pilot study show a significant change in miRNA profiles dependent on the ART outcome affecting particularly the Wnt pathway. Our findings indicate potential downstream effects influencing pregnancies and a possible prospective use as biomarkers for implantation success.
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